MAPT and Alzheimer disease: Although plasma total tau values also encompass phosphorylated forms of tau protein, a recent meta-analysis of blood-based biomarkers suggested that total tau is rather a marker of neurodegeneration, with better ability to discriminate between AD patients and controls in studies using Simoa techniques compared to traditional ELISA methods [43].